Inguinodynia — A Recognized Medical Complication
Inguinodynia is chronic pain in the inguinal (groin) region persisting for more than 3 months after inguinal hernia surgery. The International Association for the Study of Pain recognizes inguinodynia as a distinct chronic pain syndrome following groin surgery. Surgeons and pain specialists distinguish between nociceptive inguinodynia — pain from tissue damage, inflammation, or mechanical irritation — and neuropathic inguinodynia, which is pain arising from nerve injury or entrapment. Mesh-related inguinodynia is typically neuropathic in character and is therefore among the most treatment-resistant chronic pain syndromes encountered in general surgical practice.
How Mesh Causes Nerve Injury
Three mechanisms account for the majority of mesh-related nerve injury in inguinal repairs. Direct mechanical trauma occurs when tacks or staples used to fix the mesh puncture or compress a nerve during placement. Entrapment occurs as fibrotic scar tissue matures around the mesh and incorporates nerve branches into the fixed scar matrix. Tension injury occurs as shrinking mesh pulls fixation points tighter and stretches nerve segments. All three mechanisms can coexist in the same patient, complicating treatment because addressing one does not necessarily resolve the others.
Treatment for Mesh-Related Chronic Pain
The treatment algorithm for mesh-related inguinodynia typically begins with conservative measures — neuropathic medications (gabapentin, pregabalin, duloxetine), selective nerve blocks, and physical therapy. When conservative treatment fails, surgical options include neurectomy (intentional surgical division of the painful nerve), mesh removal combined with neurectomy, or both. Even after surgical intervention, complete pain resolution is not guaranteed because central sensitization — a process by which the brain becomes sensitized to pain signals and amplifies them — can perpetuate pain even after the peripheral nerve injury is addressed.
Documenting Chronic Pain for a Legal Claim
Chronic pain claims without revision surgery are legally viable but require strong documentation to support a meaningful settlement tier placement. Essential documentation includes: physician notes recording pain complaints at post-operative visits; pain specialist consultation records; prescription records for neuropathic pain medications; records of nerve block procedures; diagnostic imaging reports; and any functional capacity evaluations. A detailed pain diary maintained by the patient — documenting daily pain levels, activities limited by pain, and emotional impact — is compelling evidence that attorneys can use in settlement negotiations and trial preparation.
Frequently Asked Questions
Related Pages
Davol and C.R. Bard Hernia Mesh Products
Davol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.
Hernia Mesh Infection Claims
Hernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.
Hernia Mesh Settlements — What to Expect
Hernia mesh mass tort settlements are structured as tiered grids based on injury severity, number of revision surgeries, and individual case factors. Understanding how settlement grids work and what factors increase your tier placement helps you evaluate your claim and avoid accepting inadequate offers.
Hernia Mesh Evidence — Building Your Claim
A strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.
Ethicon and Johnson and Johnson Hernia Mesh
Ethicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.
Hernia Mesh Complications — What Can Go Wrong
Defective hernia mesh can cause a spectrum of complications from painful but treatable infections to catastrophic bowel perforation and sepsis. Understanding which complications are associated with mesh defects — versus routine surgical risks — is essential for evaluating whether a legal claim exists.
Hernia Mesh Revision Surgery — What It Involves
Hernia mesh revision surgery — including adhesiolysis, partial mesh removal, and complete explantation — is a significantly more complex and dangerous operation than the original hernia repair. The risks, costs, and recovery demands of revision surgery are core elements of damages in hernia mesh litigation.
Hernia Mesh Recall History — What the FDA Found
The FDA has issued safety communications, ordered 522 post-market surveillance studies, and presided over multiple hernia mesh recalls. The regulatory history establishes that manufacturers had notice of mesh complications well before many patients were implanted — a critical element of failure-to-warn and design defect claims.
Inguinal Hernia Mesh Claims
Inguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.
Ventral Hernia Mesh Claims
Ventral hernias — including incisional hernias following prior abdominal surgeries — are typically repaired with large sheets of synthetic mesh placed intra-abdominally or in the retromuscular space. The large surface area of ventral mesh in contact with bowel creates significant risk of adhesion, migration, and bowel obstruction.
Hernia Mesh MDL 2846 — What You Need to Know
MDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.
Hernia Mesh (Davol/C.R. Bard) Lawsuit
Hernia mesh litigation is one of the largest ongoing mass tort actions in the United States. Polypropylene mesh devices implanted during inguinal, ventral, and incisional hernia repairs have been associated with a pattern of serious defects — including mesh shrinkage, migration, erosion into adjacent organs, bacterial colonization, and nerve entrapment — that manufacturers knew about for years before disclosing to physicians or patients. The primary defendants include Davol Inc. and its parent C.R. Bard (now part of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Atrium Medical, and Covidien (now part of Medtronic). The federal multidistrict litigation MDL 2846 in the Southern District of Ohio has consolidated thousands of Davol/C.R. Bard claims for coordinated pre-trial proceedings. Separately, Ethicon mesh cases are coordinated in New Jersey Superior Court (MCL 616). Patients who underwent hernia repair surgery and subsequently experienced complications are urged to seek legal evaluation immediately — statutes of limitations are running and evidence must be preserved.
View full case overview